Web-based Tool for the Dissemination of Evidence-based Interventions for ATOD Prevention

 描述(申请人提供)：在过去的几十年里，大量针对青少年使用酒精、烟草和其他药物(ATOD)的循证治疗计划已经过严格的测试，并被证明是有效的。然而，基于证据的ATOD计划(EBP)很少在日常实践中采用，很少以强大的保真度实施，而且往往无法在其预期的服务环境中持续一段时间。越来越多的文献表明，实施质量与EBP被嵌入日常实践并实现其预期治疗结果的可能性直接相关。NIDA的战略计划明确指出，需要采取有效的方法，帮助缩小ATOD-EBPS的开发与采用之间的差距，并在服务环境中实现长期可持续性。这一第二阶段的SBIR项目将完成中心发明-ATOD的研究和开发，这是一套可定制的在线工具，专门设计用来支持“真实世界”服务环境中任何ATOD-EBP的高质量实施和可持续性。在第一阶段，我们利用关键利益相关者的迭代输入开发了Centervative-ATOD原型；将该技术基础设施应用于基于证据的ATOD预防计划；并评估了原型和提议的可扩展产品的可行性、可用性和价值。利益相关者表达了对继续研发的强烈支持，并建议扩大该产品的范围，将以干预为重点的计划包括在内，并检查成本效益结果。这个第二阶段的SBIR项目将实现三个具体目标：(1)开发和扩展中心发明-ATOD原型组件，以提高服务环境的可用性和实用性，并将第二个基于证据的ATOD计划整合到技术基础设施中。在试行测试之前，将评估Centerventive-ATOD对这一新EBP的实用性和可用性，并建议采用哪些修改措施；(2)通过试行测试评估Centervention-ATOD与传统实施方法相比，在提供商实施的熟练程度和效率、实施交付质量和EBP结果方面是否具有附加优势；以及(3)与我们的专家顾问合作，进行正式的成本效益分析，以评估使用Centervention-ATOD实施EBPS的货币和非货币成本以及收益。目前还没有其他类似的产品专门设计来帮助ATOD治疗设施实施和维持EBPS。中心发明-ATOD将利用3C研究所的技术专长和经验，创建一个灵活、可扩展的技术基础设施，适用于广泛的ATOD-EBPS，降低服务提供商的成本，提高实施质量，并增加计划的可持续性，从而提供显著社会效益的潜力，并满足巨大的商业市场。

 DESCRIPTION (provided by applicant): Over the past several decades, a large number of evidence-based treatment programs for alcohol, tobacco, and other drug (ATOD) use in youth have been rigorously tested and shown to be efficacious. Nevertheless, evidence-based ATOD programs (EBPs) are rarely adopted in everyday practice, are seldom implemented with strong fidelity, and often fail to be sustained over time in their intended service settings. A growing body of literature demonstrates implementation quality is directly related to the likelihood an EBP will be embedded into everyday practice and achieve its intended treatment outcomes. NIDA's Strategic Plan specifically identifies the need for effective methods to help close the gap between development of ATOD-EBPs and their adoption and long-term sustainability in service settings. This Phase II SBIR project will complete research and development of Centervention-ATOD, a customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within "real-world" service settings. During Phase I, we developed the Centervention-ATOD prototype with iterative input from key stakeholders; applied this technology infrastructure to an evidence-based ATOD prevention program; and evaluated the feasibility, usability, and value of the prototype and proposed scalable product. Stakeholders voiced strong support for continued research and development and suggested broadening the product's scope to include intervention- focused programs as well as examining cost-effectiveness outcomes. This Phase II SBIR project will accomplish three specific aims: (1) develop and expand Centervention-ATOD prototype components to enhance usability and utility for service settings, and integrate a second evidence-based ATOD program into the technology infrastructure. The utility and usability of Centervention-ATOD for this new EBP will be assessed and recommended modifications incorporated prior to pilot testing; (2) evaluate through pilot testing whether Centervention-ATOD confers additive benefits in provider implementation proficiency and efficacy, quality of implementation delivery, and EBP outcomes compared to traditional implementation methods; and (3) in collaboration with our expert consultant, conduct a formal cost-effectiveness analysis in order to evaluate monetary and non-monetary costs and benefits of implementing EBPs using Centervention-ATOD. No other comparable product exists that is specifically designed to help ATOD treatment facilities implement and sustain EBPs. Centervention-ATOD will leverage 3C Institute's technological expertise and experience to create a flexible, scalable technology infrastructure applicable to ATOD-EBPs on a broad scale, decreasing costs to service providers, enhancing implementation quality, and increasing program sustainability, thereby offering the potential for significant societal benefits and addressing a large, commercial market.